7.93
price up icon0.76%   0.06
after-market Handel nachbörslich: 7.93
loading
Schlusskurs vom Vortag:
$7.87
Offen:
$7.86
24-Stunden-Volumen:
1.14M
Relative Volume:
0.81
Marktkapitalisierung:
$1.23B
Einnahmen:
$53.61M
Nettoeinkommen (Verlust:
$-142.52M
KGV:
-7.1441
EPS:
-1.11
Netto-Cashflow:
$-141.83M
1W Leistung:
+2.85%
1M Leistung:
+20.70%
6M Leistung:
-31.99%
1J Leistung:
+28.42%
1-Tages-Spanne:
Value
$7.69
$8.03
1-Wochen-Bereich:
Value
$7.665
$8.73
52-Wochen-Spanne:
Value
$5.04
$16.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Name
Firmenname
Wave Life Sciences Ltd
Name
Telefon
617-949-2900
Name
Adresse
7 STRAITS VIEW, SINGAPORE
Name
Mitarbeiter
288
Name
Twitter
@WAVELifeSci
Name
Nächster Verdiensttermin
2025-03-04
Name
Neueste SEC-Einreichungen
Name
WVE's Discussions on Twitter

Vergleichen Sie WVE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
WVE
Wave Life Sciences Ltd
7.93 1.20B 53.61M -142.52M -141.83M -1.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-16 Eingeleitet Citigroup Buy
2025-06-11 Fortgesetzt Raymond James Outperform
2025-04-29 Eingeleitet Cantor Fitzgerald Overweight
2025-04-08 Eingeleitet Wedbush Outperform
2025-02-25 Eingeleitet Jefferies Buy
2024-10-16 Hochstufung Raymond James Outperform → Strong Buy
2024-09-27 Fortgesetzt JP Morgan Overweight
2024-09-19 Eingeleitet B. Riley Securities Buy
2024-09-09 Eingeleitet JP Morgan Overweight
2024-05-15 Eingeleitet Wells Fargo Overweight
2023-12-19 Hochstufung Leerink Partners Market Perform → Outperform
2023-07-05 Eingeleitet Raymond James Outperform
2023-05-24 Herabstufung Jefferies Buy → Hold
2020-12-15 Fortgesetzt H.C. Wainwright Buy
2020-10-23 Eingeleitet RBC Capital Mkts Sector Perform
2019-12-31 Herabstufung SVB Leerink Outperform → Mkt Perform
2019-11-01 Eingeleitet Guggenheim Buy
2019-07-15 Eingeleitet Cowen Market Perform
2019-04-17 Bestätigt H.C. Wainwright Buy
2018-08-07 Eingeleitet Stifel Buy
2018-07-23 Eingeleitet H.C. Wainwright Buy
2018-03-19 Bestätigt Mizuho Buy
2017-02-15 Eingeleitet H.C. Wainwright Buy
2016-11-10 Fortgesetzt Leerink Partners Outperform
2015-12-07 Eingeleitet JMP Securities Mkt Outperform
2015-12-07 Eingeleitet Jefferies Buy
2015-12-07 Eingeleitet Leerink Partners Outperform
2015-12-07 Eingeleitet Sun Trust Rbsn Humphrey Buy
Alle ansehen

Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten

pulisher
Jul 22, 2025

Why Wave Life Sciences Ltd. stock attracts strong analyst attentionFree Join Group - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Wave Life Sciences Ltd. stockRemarkably fast returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Wave Life Sciences Ltd. stock priceFree Investment Portfolio Suggestions - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Wave Life Sciences Ltd. a good long term investmentSpectacular growth rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Wave Life Sciences Ltd. Stock Analysis and ForecastAccelerated financial growth - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

(WVE) Investment Analysis - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 19, 2025

WAVE Life Sciences (NASDAQ:WVE) Research Coverage Started at Citigroup - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

Will WAVE's Q1 2025 forecast meet expectations? - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

When is the best time to buy Wave Life Sciences Ltd. stockReturn Maximized Portfolio Strategy - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

WAVE Life Sciences Receives Buy Rating and USD 16 Price Target from Citigroup - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Wave Life Sciences Unveils Promising Preclinical Data for Obesity Treatment WVE-007 at ADA Scientific Sessions - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Wave Life Sciences’ SWOT analysis: RNA editing stock poised for breakthrough - Investing.com

Jul 18, 2025
pulisher
Jul 17, 2025

Jessica Chen - White & Case LLP

Jul 17, 2025
pulisher
Jul 16, 2025

Breaking Down WAVE Life Sciences: 4 Analysts Share Their Views - Benzinga

Jul 16, 2025
pulisher
Jul 16, 2025

Citi initiates coverage on WAVE Life Sciences stock with Buy rating - Investing.com Australia

Jul 16, 2025
pulisher
Jul 16, 2025

Citi initiates coverage on WAVE Life Sciences stock with Buy rating By Investing.com - Investing.com South Africa

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Wave Life Sciences Ltd. stock price move sharplyFree Stock Index Interpretation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

13 Best Low Priced Pharma Stocks to Buy Now - Insider Monkey

Jul 15, 2025
pulisher
Jul 12, 2025

Leerink Partners Reiterates a Buy Rating on Wave Life Sciences (WVE), Keeps the PT at $24 - Yahoo Finance

Jul 12, 2025
pulisher
Jul 11, 2025

Wave Life Sciences stock reiterated Overweight by Cantor Fitzgerald - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 10, 2025

How the (WVE) price action is used to our Advantage - news.stocktradersdaily.com

Jul 10, 2025
pulisher
Jul 09, 2025

Huntington's Disease Pipeline 2025: MOA, ROA, And Clinical Trial Insights Explored By Delveinsight Spark Therapeutics, Chong Kun Dang Pharma, Neuvivo, Uniqure Biopharma, Wave Life Sciences, Novartis - Menafn.com

Jul 09, 2025
pulisher
Jul 07, 2025

Wave Life Sciences: Upgrading Rating To Buy After Turbulent 10 Months (NASDAQ:WVE) - Seeking Alpha

Jul 07, 2025
pulisher
Jul 07, 2025

We Think Wave Life Sciences (NASDAQ:WVE) Needs To Drive Business Growth Carefully - simplywall.st

Jul 07, 2025
pulisher
Jul 07, 2025

Wave Life Sciences: Speculative, But Promising (NASDAQ:WVE) - Seeking Alpha

Jul 07, 2025
pulisher
Jul 03, 2025

H.C. Wainwright Reaffirms Buy Rating on Wave Life Sciences After ADA Data Release - Yahoo Finance

Jul 03, 2025
pulisher
Jun 24, 2025

Wave Life Sciences’ SWOT analysis: RNA editing stock faces fierce competition - Investing.com

Jun 24, 2025
pulisher
Jun 23, 2025

WVE: Wedbush Reiterates Outperform Rating on WAVE Life Sciences | WVE Stock News - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

Wave Life sciences stock rating reiterated by Cantor Fitzgerald - Investing.com India

Jun 23, 2025
pulisher
Jun 21, 2025

Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007's Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions - The Manila Times

Jun 21, 2025
pulisher
Jun 20, 2025

Wave Life Sciences reports promising obesity treatment data By Investing.com - Investing.com Nigeria

Jun 20, 2025
pulisher
Jun 17, 2025

Wave Life Sciences’s SWOT analysis: RNA editing pioneer faces fierce competition - Investing.com Canada

Jun 17, 2025
pulisher
Jun 13, 2025

Insider Sell: Gregory Verdine Sells 30,000 Shares of WAVE Life S - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Insider Sell: Gregory Verdine Sells 30,000 Shares of WAVE Life Sciences Ltd (WVE) - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Wave Life Sciences (NASDAQ:WVE) Coverage Initiated at Raymond James - Defense World

Jun 13, 2025
pulisher
Jun 11, 2025

WVE Stock Update: Raymond James Rates WAVE Life Sciences 'Outper - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Receives Average Recommendation of “Buy” from Analysts - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elkedonia closes EUR 11 million seed round to advance neuroplastogens as novel therapeutics for depression and neuropsychiatric disorders - GlobeNewswire Inc.

Jun 11, 2025
pulisher
Jun 11, 2025

Equities Analysts Offer Predictions for WVE FY2026 Earnings - Defense World

Jun 11, 2025

Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):